BUZZ-Catalyst rises on upbeat 2025 revenue forecast, quarterly results beat
Reuters
Feb 28, 2025
BUZZ-Catalyst rises on upbeat 2025 revenue forecast, quarterly results beat
** Shares of drugmaker Catalyst Pharmaceuticals CPRX.O rise 7.9% to $22.21
** Company late on Wednesday forecast 2025 revenue in the range of $545 million to $565 millionn, analysts on average expect revenue to be $556.9 million, as per data compiled by LSEG
** CPRX posted fourth-quarter revenue of $141.8 million, beating analysts' estimate of $134.2 million
** Reported adj quarterly profit of 70 cents/share vs analysts' estimate of 34 cents/share
** Stock has risen 41.1% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.